Found: 83
Select item for more details and to access through your institution.
Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy: A Report of 2 Cases.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neuropilin-1 as therapeutic target for malignant melanoma.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00125
- By:
- Publication type:
- Article
CTLA-4 and PD-1 pathway blockade: combinations in the clinic.
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2014.00385
- By:
- Publication type:
- Article
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 4, p. 1, doi. 10.1007/s11912-016-0509-x
- By:
- Publication type:
- Article
Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 5, p. 500, doi. 10.1007/s11912-013-0337-1
- By:
- Publication type:
- Article
Immune‐related Adverse Events in Cancer Patients.
- Published in:
- Academic Emergency Medicine, 2018, v. 25, n. 7, p. 819, doi. 10.1111/acem.13443
- By:
- Publication type:
- Article
Patient perspectives on ipilimumab across the melanoma treatment trajectory.
- Published in:
- Supportive Care in Cancer, 2017, v. 25, n. 7, p. 2155, doi. 10.1007/s00520-017-3621-z
- By:
- Publication type:
- Article
Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.810388
- By:
- Publication type:
- Article
Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2014, v. 7, p. 357, doi. 10.2147/PGPM.S53163
- By:
- Publication type:
- Article
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 4, p. 1180, doi. 10.1245/s10434-019-08099-9
- By:
- Publication type:
- Article
Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 7, p. 1989, doi. 10.1245/s10434-017-5836-0
- By:
- Publication type:
- Article
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 84, doi. 10.1111/bjh.13528
- By:
- Publication type:
- Article
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.
- Published in:
- Experimental Dermatology, 2016, v. 25, n. 7, p. 553, doi. 10.1111/exd.13030
- By:
- Publication type:
- Article
Mucosal Melanoma: Pathogenesis, Clinical Behavior, and Management.
- Published in:
- Current Oncology Reports, 2012, v. 14, n. 5, p. 441, doi. 10.1007/s11912-012-0244-x
- By:
- Publication type:
- Article
Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma?
- Published in:
- Oncology (08909091), 2018, v. 32, n. 5, p. 228
- By:
- Publication type:
- Article
CTLA-4 Antibodies: New Directions, New Combinations.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092300
- By:
- Publication type:
- Article
Toxicities of Checkpoint Inhibitors: Causes and Management.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 4, p. 220
- By:
- Publication type:
- Article
Does Adjuvant Therapy for High-Risk Melanoma With Either Immunotherapy or Targeted Therapy Affect Therapeutic Choices at Relapse?
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 5, p. 353
- By:
- Publication type:
- Article
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 3, p. 690, doi. 10.1002/cam4.1356
- By:
- Publication type:
- Article
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1340979
- By:
- Publication type:
- Article
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1961, doi. 10.1093/neuonc/noab094
- By:
- Publication type:
- Article
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).
- Published in:
- 2018
- By:
- Publication type:
- research
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
- Published in:
- 2017
- By:
- Publication type:
- historical material
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 3, p. 399, doi. 10.1038/cr.2015.28
- By:
- Publication type:
- Article
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
- Published in:
- Cell Research, 2015, v. 25, n. 2, p. 208, doi. 10.1038/cr.2015.3
- By:
- Publication type:
- Article
Clonally expanded CD38<sup>hi</sup> cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis.
- Published in:
- Science Immunology, 2023, v. 8, n. 85, p. 1, doi. 10.1126/sciimmunol.add1591
- By:
- Publication type:
- Article
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aar3342
- By:
- Publication type:
- Article
On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 280, p. 1, doi. 10.1126/scitranslmed.3010274
- By:
- Publication type:
- Article
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 2, p. 193, doi. 10.1093/cid/ciz202
- By:
- Publication type:
- Article
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1490, doi. 10.1093/cid/ciw539
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
Title: CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262485
- By:
- Publication type:
- Article
First-in-human imaging with <sup>89</sup>Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229781
- By:
- Publication type:
- Article
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Future perspectives in melanoma research.
- Published in:
- Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1070-y
- By:
- Publication type:
- Article